Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

New Strategies Needed As China Shakes Up Drug Class Rules?

This article was originally published in SRA

Executive Summary

Like a stone being thrown into a pool of calm water, the China Food and Drug Administration released on March 9 "Document 51, Reform Plans for Chemical Drug Registration", stirring up immediate reactions from the pharma industry1.

Advertisement

Related Content

2016 Review: Rapid Change Defines China Regulatory Environment
Advertisement
UsernamePublicRestriction

Register